• Wrong document? Swap it for free
  • Written by students who passed
  • Immediately available after payment
  • Read online or as PDF
Sell
Where do you study
Your language
Document preview thumbnail
Preview 3 out of 27 pages
Exam (elaborations)

Advanced Clinical Neuromodulation Examination – Comprehensive Examination Material

Document preview thumbnail
Preview 3 out of 27 pages

Advanced Clinical Neuromodulation Examination study material covering neuromodulation principles, clinical applications, treatment techniques, patient assessment, device management, safety considerations, therapeutic approaches, and clinical decision-making. Designed to support focused study, review, and comprehensive examination preparation.

Content preview

ADVANCED CLINICAL NEUROMODULATION
EXAMINATION – COMPREHENSIVE EXAMINATION
MATERIAL


1. Which mechanism best describes the therapeutic effect of deep brain stimulation (DBS) in
Parkinson disease?
A) Irreversible thermal lesioning of the globus pallidus
B) Reversible modulation of pathological neural circuits
C) Direct dopaminergic cell replacement
D) Permanent inhibition of the subthalamic nucleus
Answer: B
Rationale: DBS uses implanted electrodes to deliver adjustable electrical pulses that reversibly modulate
dysfunctional neural circuits rather than destroying tissue.




2. Which DBS target is most commonly used for medication-refractory Parkinson disease tremor?
A) Subthalamic nucleus
B) Globus pallidus interna
C) Ventral intermediate nucleus of the thalamus
D) Anterior nucleus of the thalamus
Answer: C
Rationale: The ventral intermediate nucleus of the thalamus is a well-established target for tremor-
predominant Parkinson disease and essential tremor.




3. Which DBS target is most commonly used for generalized dystonia?
A) Ventral intermediate nucleus
B) Globus pallidus interna
C) Subthalamic nucleus
D) Anterior cingulate cortex
Answer: B

,Rationale: Globus pallidus interna stimulation is the preferred DBS target for primary generalized dystonia
and many focal dystonias.




4. Which DBS target has an FDA humanitarian device exemption for treatment-refractory obsessive-
compulsive disorder?
A) Anterior limb of the internal capsule
B) Ventral intermediate nucleus
C) Subthalamic nucleus
D) Hippocampus
Answer: A
Rationale: DBS of the anterior limb of the internal capsule, often including the ventral capsule/ventral
striatum, has an FDA humanitarian device exemption for severe OCD.




5. Which DBS target is used for drug-resistant epilepsy?
A) Anterior nucleus of the thalamus
B) Globus pallidus interna
C) Ventral intermediate nucleus
D) Pedunculopontine nucleus
Answer: A
Rationale: Anterior nucleus of the thalamus DBS is approved for drug-resistant epilepsy in many regions
and is supported by randomized trial evidence.




6. Which parameter is typically increased first when programming DBS to improve symptom control?
A) Pulse width
B) Frequency
C) Amplitude
D) Impedance
Answer: C
Rationale: Amplitude is usually titrated first because it has the most immediate effect on symptom control,
while monitoring for stimulation-induced adverse effects.




7. Which adverse effect is most associated with subthalamic nucleus DBS?
2

, A) Visual field deficits
B) Impulsive or hypomanic behavior
C) Persistent anosmia
D) Peripheral neuropathy
Answer: B
Rationale: Subthalamic nucleus stimulation can affect limbic and associative circuits, producing impulsivity,
hypomania, or apathy in some patients.




8. Which adverse effect is most associated with globus pallidus interna DBS?
A) Cognitive decline
B) Depression
C) Visual field deficits
D) Seizures
Answer: C
Rationale: The globus pallidus interna lies near the optic tract, so stimulation can cause visual field deficits if
current spreads to nearby structures.




9. Which technique uses a magnetic coil to induce electrical currents in cortical tissue?
A) Vagus nerve stimulation
B) Transcranial magnetic stimulation
C) Spinal cord stimulation
D) Deep brain stimulation
Answer: B
Rationale: Transcranial magnetic stimulation generates a rapidly changing magnetic field that induces
electrical currents in superficial cortical neurons.




10. Which rTMS protocol is FDA-cleared for treatment-resistant major depressive disorder?
A) Continuous theta burst over the right dorsolateral prefrontal cortex
B) High-frequency stimulation over the left dorsolateral prefrontal cortex
C) Low-frequency stimulation over the left motor cortex
D) Bilateral stimulation over the occipital cortex
Answer: B


3

Document information

Uploaded on
October 8, 2026
Number of pages
27
Written in
2026/2027
Type
Exam (elaborations)
Contains
Questions & answers
$21.99

Wrong document? Swap it for free Within 14 days of purchase and before downloading, you can choose a different document. You can simply spend the amount again.
Written by students who passed
Immediately available after payment
Read online or as PDF

Seller avatar
Reputation scores are based on the amount of documents a seller has sold for a fee and the reviews they have received for those documents. There are three levels: Bronze, Silver and Gold. The better the reputation, the more your can rely on the quality of the sellers work.
Sold
34
Followers
0
Items
1506
Last sold
3 days ago



Why students choose Stuvia

Created by fellow students, verified by reviews

Quality you can trust: written by students who passed their tests and reviewed by others who've used these notes.

Didn't get what you expected? Choose another document

No worries! You can instantly pick a different document that better fits what you're looking for.

Pay as you like, start learning right away

No subscription, no commitments. Pay the way you're used to via credit card and download your PDF document instantly.

Student with book image

“Bought, downloaded, and aced it. It really can be that simple.”

Alisha Student

Working on your references?

Create accurate citations in APA, MLA and Harvard with our free citation generator.

Working on your references?

Frequently asked questions